Effectiveness of Convalescent Plasma Therapy in COVID-19 Patients with Hematological Malignancies: A Systematic Review

Background: Immunocompromised patients, including those with hematological malignancies, are at a high risk of developing severe coronavirus disease 2019 (COVID-19) complications. Currently, there is a limited number of systematic reviews into the efficacy of convalescent plasma therapy (CPT) use in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibeeb, Sapha, Ajaj, Ilham, Al-Jighefee, Hadeel, Abdallah, Atiyeh M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778836/
https://www.ncbi.nlm.nih.gov/pubmed/36547236
http://dx.doi.org/10.3390/hematolrep14040052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778836/
https://www.ncbi.nlm.nih.gov/pubmed/36547236
http://dx.doi.org/10.3390/hematolrep14040052

Ejemplares similares